GAIN THERAPEUTICS INC's ticker is GANX and the CUSIP is 36269B105. A total of 17 filers reported holding GAIN THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,264 | +19.0% | 1,300 | +62.5% | 0.00% | – |
| Q2 2023 | $3,584 | -7.1% | 800 | 0.0% | 0.00% | – |
| Q1 2023 | $3,856 | +54.0% | 800 | 0.0% | 0.00% | – |
| Q4 2022 | $2,504 | -37.4% | 800 | -24.0% | 0.00% | – |
| Q3 2022 | $4,000 | +33.3% | 1,052 | +31.5% | 0.00% | – |
| Q2 2022 | $3,000 | 0.0% | 800 | -0.4% | 0.00% | – |
| Q1 2022 | $3,000 | -25.0% | 803 | +0.4% | 0.00% | – |
| Q4 2021 | $4,000 | -33.3% | 800 | 0.0% | 0.00% | – |
| Q3 2021 | $6,000 | -25.0% | 800 | 0.0% | 0.00% | – |
| Q2 2021 | $8,000 | -33.3% | 800 | 0.0% | 0.00% | – |
| Q1 2021 | $12,000 | – | 800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CM Management, LLC | 90,000 | $295,200 | 0.31% |
| Greenlight Capital | 588,410 | $1,929,985 | 0.11% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 58,100 | $190,568 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 46,100 | $148,903 | 0.00% |
| Householder Group Estate & Retirement Specialist, LLC | 2,500 | $8,200 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| HM PAYSON & CO | 1,000 | $3,280 | 0.00% |
| GROUP ONE TRADING, L.P. | 1,937 | $6,257 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 151,476 | $489,355 | 0.00% |
| MORGAN STANLEY | 1,300 | $4,264 | 0.00% |